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Breast cancer is the most common malignancy in women. The most 
common pathologic subtypes of 
breast cancer originate in the terminal 
duct lobular unit in either the ducts 
(ductal carcinoma) or lobules (lobular 
carcinoma). These subtypes account 
for 80%–85% of primary breast 
cancers. The origin of the breast 
cancer can only be determined by the 
microscopic appearance of the cancer 
cells obtained at biopsy. 
Usually, breast cancers manifest 
as irregularly shaped masses, with or 
without microcalcifications. Therefore, 
many breast cancers are diagnosed 
on the basis of these findings at 
mammography or ultrasonography 
(US). 
Although most well-circumscribed 
breast lesions are benign, 10%–20% 
of breast malignancies are also well-
circumscribed; these malignant masses 
include papillary, mucinous, medullary, 
and metaplastic carcinomas, as well 
as malignant phyllodes tumors. Such 
lesions may be difficult to recognize as 
malignant using conventional imaging 
modalities such as mammography and 
US. 
MR imaging has been widely used 
for detecting and assessing breast 
lesions. MR imaging is sensitive 
for detecting breast cancers, with 
a sensitivity as high as 100% for 
invasive breast cancers, and therefore 
has emerged as an adjunctive breast 
imaging modality to mammography 
and US. MR imaging has limitations 
in lesion characterization, but it is still 
useful as an adjunct for differentiating 
between benign breast lesions and 
benign-looking breast cancers. It is also 
useful for evaluating dense breasts.
Papillary Carinomas may be 
located in a duct or within a cyst and 
are therefore mostly located in the 
retroareolar region. The lesions may be 
in-situ or invasive. On mammography, 
papillary carcinomas appear as well-
defined dense lesions (Fig 1a). On 
US, intracystic lesions tend to show 
internal haemorrhage and also contain 
solid components within the cyst (Fig 
1b). The solid component may show 
hypervascularity on Doppler US. 
MR imaging will show smooth lesion 
margins, areas of haemorrhage (fig 
1c), cystic fluid (fig 1d), strong contrast 
enhancement of the rim and solid 
polypoid components (fig 1e) and a 
temporal contrast enhancement pattern 
indicative of malignant disease (fig 1f). 
Invasive and non-invasive papillary 
cancers have similar appearances on 
US, mammography and MR imaging. 
figure 1a. Mammogram showing an intracystic 
papillary carcinoma as an oval well-circumscribed 
high-density mass (arrow).
figure 1b. US demonstrates a solid mass (solid 
arrow) within a cystic lesion with mild posterior 
acoustic enhancement (open arrow).
figure 1c. T1-weighted MR scan of an intracystic 
papillary carcinoma showing central high T1 
signal (bright area) (arrow) within the lesion that is 
compatible with haemorrhage. 
figure 1d. T2-weighted MR scan of an intracystic 
papillary carcinoma showing areas of high T1 
signal (bright areas) within the lesion compatible 
with cyst fluid. Black areas (arrows) within the 
lesion are due to deposits of haemosiderin 
resulting from older haemorrhage. 
figure 1e. Axial contrast material–enhanced 
T1-weighted MR image demonstrates marked 
enhancement of the cystic wall (black arrow) and 
mural nodules (white arrow).
figure 1f. The dynamic enhancement pattern 
(signal intensity y axis against time x axis) 
following (Gadolinium-based) contrast agent 
injection shows marked early enhancement and 
also an early washout pattern in the solid portion 
of the lesion that are features of malignancy (Type 
III pattern).
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Mucinous (or colloid) carcinoma 
contains large amounts of extracellular 
extraluminal mucus in direct contact 
with the stroma. It is more common in 
elderly women and usually has a good 
prognosis. Areas of invasive ductal 
cancer are however often intermixed 
within these lesions, which makes the 
prognosis less favorable. Mucinous 
carcinoma commonly presents as a 
well-circumscribed round, oval, or 
lobular mass on mammography (Fig 
2a) and US. Mixed cystic and solid 
components and the presence of 
posterior acoustic enhancement may 
be seen at US (Fig 2b). Mucinous 
carcinoma shows variable signal 
intensity on T1-weighted MR images, 
depending on protein concentration 
within the tumor (Fig 2c), and is 
homogeneously or heterogeneously 
hyperintense on T2-weighted images 
(Fig 2d), which correlates with the large 
mucinous component at histologic 
examination. Dynamic contrast 
enhanced T1 weighted scans show 
marked early enhancement with 
washout (as in Fig 1f) or persistent 
enhancement (as in Fig 2e). 
Medullary carcinoma is an 
uncommon tumor that accounts for 
less than 5% of all breast cancers. It 
has been reported to account for 11% 
of all breast carcinomas diagnosed 
in women 35 years and younger and 
has a relatively favorable prognosis. 
Medullary carcinoma manifests as 
a round, oval, noncalcified mass 
with a well-circumscribed margin at 
mammography (Fig 3a) and as a well-
circumscribed hypoechoic lesion with 
no dorsal enhancement at US (Fig 3b). 
figure 2a. Mucinous carcinoma on a 
mammogram shows a lobular well-circumscribed 
mass lesion (arrow).
figure 2b. Mucinous carcinoma on US seen 
as a round microlobulated mass with posterior 
acoustic enhancement.
figure 2c. T2-weighted MR image shows a 
homogeneously hyperintense lobular mass with a 
smooth margin.
figure 2d. Contrast-enhanced MR image shows 
peripheral rim enhancement and an internal 
nonenhancing portion. 
figure 2e. The dynamic enhancement pattern 
is the type I persistent pattern phyllodes tumor 
(arrows). 
Medullary carcinomas show marked 
homogeneous enhancement on MRI (Fig 
3c) with a plateau phase (ie no washout) 
(Fig 3d).
Metaplastic breast carcinoma is 
regarded as a ductal carcinoma that 
has undergone metaplasia into a 
nonglandular growth pattern, including 
squamous cell, spindle cell, and 
heterogeneous mesenchymal growth 
patterns. It is a rare type of cancer 
accounting for only 1% of cases and 
presents more commonly after the age 
of 50 years. Metaplastic carcinoma 
usually presents as a rapidly growing 
mass with no axillary lymphadenopathy. 
It appears as a well circumscribed lesion 
on mammography (Fig 4a) and US, 
being hypoechoic or heterogeneous with 
mixed solid and cystic components on 
US (Fig 4b).  T2-weighted MRI scans 
demonstrate the lesion as bright due 
to the cystic components (Fig 4c). On 
the other hand contrast-enhanced T1-
weighted scans show rim enhancement 
(as cystic components do not enhance) 
(Fig 4d). A type III enhancement pattern 
is seen on dynamic MR study (Fig 4e). 
Phyllodes tumors are composed 
of a mixture of epithelial elements and 
a connective tissue stroma. Most are 
benign but intermediate and malignant 
forms also occur. All three forms of 
phyllodes tumors have a high recurrence 
rate. On mammography, a phyllodes 
tumor appears as a large relatively 
well-circumscribed soft-tissue mass, 
showing an appearance similar to 
a fibroadenoma. US shows a solid 
hypoechoic mass often with cystic 
areas, the latter being more common 
in malgnant lesions. T2-weighted 
MRI scans demonstrate the cystic 
components, while contrast enhanced 
T1-weighted MRI shows heterogeneous 
enhancement (Fig 5a). Dynamic 
MR studies show a Type III contrast 
enhancement pattern (Fig 5b). 
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figure 3a. Medullary carcinoma in a 28-year-old 
woman presents as a lobular mass (arrow) on 
mammography. 
figure 4a. Focal compression mammography 
shows a metaplastic carcinoma with mostly well-
defined margins (arrow).
figure 4d. Contrast enhanced T1-weighted MRI 
scan shows ring enhancement (arrow) of the 
lesion. 
figure 3c. Medullary carcinoma appears as 
a rounded well-defined lesion homogeneous 
contrast enhancement on MRI. 
figure 4c. T2-weighted MRI scan of the 
same lesion shows high signal due to cystic 
components. 
figure 5a. Contrast-enhanced T1-weighted MRI 
scan showing heterogeneous enhancement in a 
figure 3b. US of the same lesion shows a lobular 
hypoechoic mass with a well-defined margins and 
no dorsal enhancement.
figure 4b. US shows the same lesion with well-
defined margins and heterogeneous internal 
texture with solid (black arrow) and cystic (white 
arrow) componements.
figure 4e. Dynamic contrast MR study shows a 
Type III enhancement pattern.
figure 3d. Dynamic contrast examination 
shows a type II pattern with rapid and sustained 
enhancment.
figure 5b. A type III contrast enhancement 
pattern is seen in a phyllodes tumor. 
In summary, a number of malignant 
lesions have a benign appearance 
on mammography and US. MR 
morphology, contrast uptake and 
dynamic enhancement pattern analysis 
serve as a valuable adjunct for correct 
diagnosis in these cases. High T2 
signal, strong and rapid contrast uptake 
with sustained enhancement or early 
washout are features of malignant 
disease.  
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